Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kirsten Neubert"'
Autor:
Diana Dudziak, Anna Baranska, Christian Lehmann, Lukas Amon, Gordon F. Heidkamp, Nathalie EissIng, Simone Beck, Claudia Gerlach, Kirsten Neubert, Rainer Spang, Elke Krüger, Antje Voigt, Kai Hildner, Falk Nimmerjahn, Jil Sander, Joachim Schultze
Publikováno v:
Molecular Immunology. 150:34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d98298e0ad4ec4b136b51eccfb67346
https://doi.org/10.1016/j.molimm.2022.05.113
https://doi.org/10.1016/j.molimm.2022.05.113
Autor:
Jeffrey V. Ravetch, Jennifer J. Lühr, Simone Beck, Christin Brückner, Alana Hoffmann, Lukas Heger, Diana Dudziak, Christian H. K. Lehmann, Anna Baranska, Jeanette H. W. Leusen, Anne Krug, Kirsten Neubert, Melissa Kießling, Katharina C. Reimer, Didier Soulat, Michaela Seeling, Gordon F. Heidkamp, Falk Nimmerjahn
Publikováno v:
Journal of Experimental Medicine
Journal of Experimental Medicine, Rockefeller University Press, 2017, 214 (5), pp.1509-1528. ⟨10.1084/jem.20160951⟩
The Journal of Experimental Medicine
Journal of Experimental Medicine, 214(5), 1509. Rockefeller University Press
Journal of Experimental Medicine, 2017, 214 (5), pp.1509-1528. ⟨10.1084/jem.20160951⟩
Journal of Experimental Medicine, Rockefeller University Press, 2017, 214 (5), pp.1509-1528. ⟨10.1084/jem.20160951⟩
The Journal of Experimental Medicine
Journal of Experimental Medicine, 214(5), 1509. Rockefeller University Press
Journal of Experimental Medicine, 2017, 214 (5), pp.1509-1528. ⟨10.1084/jem.20160951⟩
Lehmann et al. targeted antigens to Fcγ receptors expressed on various antigen-presenting cells. Induced CD4+ and CD8+ T cell responses were solely dependent on CD11b+ and CD8+ DC subsets, respectively, but independent of receptor intrinsic ITAM or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa712750334d0f64d74647abcd5fbf2
https://hal.archives-ouvertes.fr/hal-01996170
https://hal.archives-ouvertes.fr/hal-01996170
Autor:
Gordon F. Heidkamp, Anna Maria Staedtler, Falk Nimmerjahn, Michel C. Nussenzweig, Lukas Heger, Anna Baranska, Sayuri Yamazaki, Diana Dudziak, Henry Zebroski, Veit R. Buchholz, Nathalie Eissing, Kirsten Neubert, Christian H. K. Lehmann
Publikováno v:
The Journal of Immunology. 192:5830-5838
Dendritic cells (DCs) are central modulators of immune responses and, therefore, interesting target cells for the induction of antitumor immune responses. Ag delivery to select DC subpopulations via targeting Abs to DC inhibitory receptor 2 (DCIR2, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864422894c75eb6d2981c1c4480ff57d
https://doi.org/10.4049/jimmunol.1300975
https://doi.org/10.4049/jimmunol.1300975
Autor:
Reinhard E. Voll, Hans-Martin Jäck, Dirk Mielenz, Silke Meister, Georg Schett, Christina Böhm, Kirsten Neubert, Veronika Lang
Publikováno v:
The Journal of Immunology. 185:5637-5647
The proteasome inhibitor bortezomib is approved for the treatment of multiple myeloma and mantle cell lymphoma. We recently demonstrated that bortezomib eliminates autoreactive plasma cells in systemic lupus erythematosus mouse models, thereby repres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91ec468a9654525256f7a26b14e5924b
https://doi.org/10.4049/jimmunol.1001040
https://doi.org/10.4049/jimmunol.1001040
Autor:
Christian H. K. Lehmann, Anna Baranska, Gordon F. Heidkamp, Lukas Heger, Kirsten Neubert, Jennifer J. Lühr, Alana Hoffmann, Katharina C. Reimer, Christin Brückner, Simone Beck, Michaela Seeling, Melissa Kießling, Didier Soulat, Anne B. Krug, Jeffrey V. Ravetch, Jeanette H.W. Leusen, Falk Nimmerjahn, Diana Dudziak
Publikováno v:
The Journal of Immunology. 200:181.17-181.17
Dendritic cells (DCs) are important antigen presenting cells (APCs) and responsible for the induction of immune responses and preserving peripheral tolerance. We showed that targeting of antigens via C-type lectin receptors to different specialized D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48bc3df59beee768d80e571ef1821502
https://doi.org/10.4049/jimmunol.200.supp.181.17
https://doi.org/10.4049/jimmunol.200.supp.181.17
Publikováno v:
Future Rheumatology. 3:311-315
Reinhard E Voll†, Kirsten Neubert, Silke Meister, Eva Guckel & Joachim R Kalden †Author for correspondence University of ErlangenNuremberg, Interdisciplinary Center for Clinical Research, IZKF-N2, Nikolaus-FiebigerCenter of Molecular Medicine, Gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c888bebbb75b8a46dfd3a9f574d4dfc
https://doi.org/10.2217/17460816.3.4.311
https://doi.org/10.2217/17460816.3.4.311
Publikováno v:
Cell Death & Differentiation. 15:600-612
The proteasome inhibitor bortezomib, which induces cell death in various cancer cell lines including lymphatic neoplasias, has recently been approved for the treatment of relapsed multiple myeloma. Important mechanisms of proteasome inhibitor-mediate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839e971da34529c4de4a3b17db73bef6
https://doi.org/10.1038/sj.cdd.4402297
https://doi.org/10.1038/sj.cdd.4402297
Autor:
Hans-Martin Jäck, Sandra Schreiber, Kai Herrmann, Reinhard E. Voll, Renate Burger, Ulrich Schubert, Sabine Wilhelm, Sabine Hahn, Kirsten Neubert, Martin Gramatzki, Silke Meister, Martin Herrmann
Publikováno v:
Cancer Research. 67:1783-1792
Multiple myeloma is an incurable plasma cell neoplasia characterized by the production of large amounts of monoclonal immunoglobulins. The proteasome inhibitor bortezomib (PS-341, Velcade) induces apoptosis in various malignant cells and has been app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b9e63d989f2863eee3229347cc4ac6
https://doi.org/10.1158/0008-5472.can-06-2258
https://doi.org/10.1158/0008-5472.can-06-2258
Autor:
Kirsten Neubert, Reinhard E. Voll, Martin Herrmann, Damian Maseda, Vilma Urbonaviciute, Irute Girkontaite
Publikováno v:
Autoimmunity. 40:327-330
Apoptotic cells are readily recognized and engulfed by phagocytes and usually do not induce inflammation or tissue damage. Furthermore, they can actively suppress a pro-inflammatory response in phagocytes: In the presence of apoptotic cells, activate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bd6dddc02985c10fe05d57e963f028b
https://doi.org/10.1080/08916930701356846
https://doi.org/10.1080/08916930701356846
Autor:
Luis E. Muñoz, Kirsten Neubert, Joachim R. Kalden, Hagen von Briesen, Ahmed Sheriff, Barbara G. Fürnrohr, Martin Herrmann, Reinhard E. Voll, Vilma Urbonaviciute
Publikováno v:
Signal Transduction. 5:356-365
Cell death can occur controlled by apoptosis or rather uncontrolled by necrosis. The decision to initiate an inflammatory response has to be made for dying cells, which arise by hundreds of billions each day. They carry valuable information with resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::591b5f3ed8df32d91ad7c690269fb666
https://doi.org/10.1002/sita.200500071
https://doi.org/10.1002/sita.200500071